Chronic Myelomonocytic Leukemia

Common Name(s)

Chronic Myelomonocytic Leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chronic Myelomonocytic Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chronic Myelomonocytic Leukemia" returned 136 free, full-text research articles on human participants. First 3 results:

[Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case].
 

Author(s): Javier Zelada, Gabriela Cantó, Alejandro Berkovits, Gonzalo Diocares, Adriana López

Journal: Rev Med Chil. 2015 Nov;143(11):1490-3.

 

Bleeding disorders are commonly associated with hemato-oncologic diseases. We report a 68 years old male with a chronic myelomonocytic leukemia derived from a long lasting mielodysplastic syndrome that did not respond to treatment with Azacitidine. The patient was hospitalized due ...

Last Updated: 13 Jan 2016

Go To URL
Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
 

Author(s): Hisao Imai, Nozomi Matsumura, Yuichi Yamazaki, Yuki Kanayama, Tomomi Masuda, Tomohito Kuwako, Yosuke Kamide, Taku Tomizawa, Shunichi Matsumoto, Takeki Mitsui, Kyoichi Kaira, Akihiro Ono, Yasuhiko Koga, Nobuyuki Shibusawa, Noriaki Sunaga, Takeshi Hisada, Hideaki Yokoo, Masanobu Yamada

Journal: Intern. Med.. 2015 ;54(24):3171-6.

 

We describe the case of an 85-year-old man diagnosed with chronic myelomonocytic leukemia whose disease was treated with hydroxyurea for 3 months. He developed respiratory symptoms that were extensively investigated. Despite the intensive treatment, he died of respiratory failure ...

Last Updated: 15 Dec 2015

Go To URL
Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever.
 

Author(s): Fawaz Awad, Sophie Georgin-Lavialle, Anne Brignier, Coralie Derrieux, Achille Aouba, Katia Stankovic-Stojanovic, Gilles Grateau, Serge Amselem, Olivier Hermine, Sonia-Athina Karabina

Journal:

 

We report on a familial Mediterranean fever (FMF) patient homozygous for p.M694V in the MEFV gene who developed chronic myelomonocytic leukemia (CMML) leading to an uncontrolled and fatal inflammatory syndrome. Plasma levels of IL-6 and IL-18 were found to be very high, as compared ...

Last Updated: 30 Jun 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chronic Myelomonocytic Leukemia" returned 7 free, full-text review articles on human participants. First 3 results:

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
 

Author(s): Bing Li, Robert Peter Gale, Zhijian Xiao

Journal:

 

According to the 2008 World Health Organization classification, chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia are rare diseases. The remarkable progress in our understanding of the molecular genetics of myeloproliferative neoplasms ...

Last Updated: 18 Dec 2014

Go To URL
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.
 

Author(s): Francesco Onida, Giovanni Barosi, Giuseppe Leone, Luca Malcovati, Enrica Morra, Valeria Santini, Giorgina Specchia, Sante Tura

Journal: Haematologica. 2013 Sep;98(9):1344-52.

 

With the aim of reviewing critical concepts and producing recommendations for the management of chronic myelomonocytic leukemia, key questions were selected according to the criterion of clinical relevance. Recommendations were produced using a Delphi process and four consensus conferences ...

Last Updated: 5 Sep 2013

Go To URL
Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
 

Author(s): Sameer A Parikh, Ayalew Tefferi

Journal: Am. J. Hematol.. 2013 Nov;88(11):967-74.

 

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that is classified as a myelodysplastic/myeloproliferative neoplasm by the 2008 World Health Organization classification of hematopoietic tumors. It is characterized by absolute monocytosis (>1 × 10⁹/L) ...

Last Updated: 24 Oct 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 22 Jul 2016

Go to URL
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
 

Status: Recruiting

Condition Summary: Chronic Myelomonocytic Leukemia

 

Last Updated: 25 Feb 2016

Go to URL
SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)
 

Status: Recruiting

Condition Summary: Myelofibrosis; Chronic Myelomonocytic Leukemia; Advanced Systemic Mastocytosis; Advanced Symptomatic Primary Eosinophilic Disorder

 

Last Updated: 6 Jul 2016

Go to URL